Could a new rash in a patient taking a GLP-1 agent be coincidence, or is it medication-related
How to reduce the risk of hair loss while using GLP-1 medication Patients should not stop prescribed medication without speaking to their doctor
Efficacy and tolerability of propolis special extract gh 2002 as a lip balm against herpes labialis: a randomized, double-blind three-arm dose finding study
While Mounjaros clinical results are promising, differentiation versus Ozempic is not clean cut, as clinical results appear to be dose dependent, and Ozempic may have a slight advantage in terms of gastrointestinal (GI) tolerability and dropout rates (discontinuation rates due to adverse events in tirzepatide arms were 5.1% 7.9% compared to 3.8% in semaglutide cohort)
64,67,69 One of these studies reported no association between breast cancer risk and COC use
Managing side effects during dose increases Gastrointestinal side effects such as nausea, vomiting, and diarrhea are common while taking GLP-1 medication and usually appear during the start of the medication or when the dose is increased
